Information
- Information
Nikkan Yakugyo and AnswersNews published articles about the launch of Elix Discovery™, Elix’s AI drug discovery platform
- Information
Elix’s CEO Shinya Yuki has been appointed as the secretary of the Society of Computational Toxicology
- Information
Elix CEO Shinya’s interview was published in The Pharma Letter
- Information
Elix will exhibit the booth at “Pharma IT & Digital Health Expo 2022”
- Information
Joint research with SHIONOGI & CO., LTD. for verification of practical retrosynthetic analysis was introduced in BioWorld and The Pharma Letter
- Information
Elix CEO Shinya Yuki will give an online lecture on this Friday, April 1st 2022 from 19:00 JST
- News Release
Elix, Inc. begins collaboration with Shionogi & Co., Ltd. on Elix Synthesize (AI Drug Discovery Module) for verification of practical retrosynthetic analysis
- Information
Joint research with SHIONOGI & CO., LTD. was introduced in Nikkei Xtech (March 18, 2022)
- Information
Joint research with SHIONOGI & CO., LTD. was introduced in The Chemical Daily (February 28, 2022)